Darling Ingredients Inc. DAR R3K
Company Overview
Darling Ingredients Inc. develops, produces, and sells sustainable natural ingredients from edible and inedible bio-nutrients in North America, Europe, China, South America, and internationally. The Feed Ingredients segment collects and processes animal by-products into non-food grade oils and protein meals; bakery residuals into cookie meal used in poultry and swine rations; used cooking oil into non-food grade fats; and porcine and bovine blood into blood plasma powder and hemoglobin. This segment is also involved in the processing of selected portions of slaughtered animals into pet food, as well as of cattle hides and hog skins; production of organic fertilizers; rearing and processing of black soldier fly larvae into specialty proteins and fats for use in animal feed and pet food; and grease trap collection services to food service establishments. Its Food Ingredients segment engages in the purchase and processing of beef and pork bone chips, beef hides, and pig and fish skins into collagen; collection and processing of porcine and bovine intestines into natural casings; extraction and processing of porcine mucosa into crude heparin; collection and refining of animal fat into food grade fat; and processing of bones to bone chips and bone ash. The Fuel Ingredients segment is involved in the conversion of organic sludge and food waste into biogas; collection and conversion of fallen stock and certain animal by-products into low-grade energy sources; and processing of manure into natural bio-phosphate. It also provides environmental services, including disposal services; and yellow grease, fuel feedstock, and agriculture-based biofuels. The company sells its products under the Rendac, Sonac, FASA, Ecoson, Rousselot, Gelnex, and CTH brands. The company was formerly known as Darling International Inc. and changed its name to Darling Ingredients Inc. in May 2014. Darling Ingredients Inc. was founded in 1882 and is headquartered in Irving, Texas.
Why Investors Should Care
Revenue has grown at a 11.9% CAGR over the past five years.
Trades at a P/E of 18.0, below the sector median of 18.6.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Jan 2026 Revenue of $6.14B (+0.0% YoY); net profit $62.80M.
- Trailing 12 Months Year-on-year growth — revenue +16.4%, earnings +2914.0%.
- 5-Year Trend Long-term compounding — revenue CAGR 11.9%, profit CAGR 0.8%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 11.93% |
| 1 Year: | 16.40% |
Compounded Profit Growth
| 5 Years: | 0.78% |
| 1 Year: | 2,914.00% |
Stock Price Performance
| 1 Year: | +109.39% |
| 6 Months: | +29.26% |
| 3 Months: | +14.99% |
| 1 Month: | +12.96% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)58.03 · Neutral
P/E of 18.04 is below the sector median of 18.56 — relatively cheaper than peers.
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Compounding revenue at 11.9% over 5 years.
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Consumer Defensive).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | DAR Darling Ingredients Inc. R3K | 67.11 | 18.04 | $10.59B | 0.00% | 2.95% | 12.13% | 11.93% | 0.78% |
| 2 | WMT Walmart Inc. SPXR3K | 107.14 | 38.82 | $850.02B | 0.93% | 16.83% | 22.31% | 3.82% | 3.24% |
| 3 | COST Costco Wholesale Corporation NDXSPXR3K | 910.18 | 45.88 | $403.65B | 0.65% | 25.96% | 29.15% | 8.16% | 11.45% |
| 4 | KO The Coca-Cola Company SPXR3K | 88.36 | 26.53 | $380.17B | 2.41% | 16.47% | 42.05% | 2.86% | 4.46% |
| 5 | PG The Procter & Gamble Company SPXR3K | 145.58 | 21.99 | $338.39B | 2.95% | 22.49% | 30.29% | 0.52% | 1.59% |
| 6 | PM Philip Morris International Inc. SPXR3K | 184.73 | 25.37 | $287.92B | 3.09% | 34.03% | -113.55% | -1.69% | 3.57% |
| 7 | PEP PepsiCo, Inc. NDXSPXR3K | 138.45 | 18.15 | $189.12B | 4.43% | 15.41% | 51.51% | 4.93% | 2.11% |
| 8 | BUD Anheuser-Busch InBev SA/NV | 79.73 | 17.18 | $139.30B | 1.69% | 8.49% | 11.39% | 0.88% | 4.63% |
| 9 | BTI British American Tobacco p.l.c. | 55.15 | 14.18 | $118.73B | 5.98% | 12.44% | 13.42% | -2.53% | 5.21% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Jul 2015 | Oct 2015 | Jan 2016 | Apr 2016 | Jul 2016 | Oct 2016 | Dec 2016 | Apr 2017 | Jul 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Jan 2021 | Apr 2021 | Jul 2021 | Oct 2021 | Apr 2022 | Jul 2022 | Oct 2022 | Apr 2023 | Jul 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Apr 2026 | Jul 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | 878.51M | 894.93M | 936.26M | 952.55M | 878.51M | 894.93M | 936.26M | - | 875.37M | 846.65M | 812.58M | 853.13M | 835.10M | 827.32M | 842.05M | 859.43M | 852.84M | 848.67M | 850.57M | 1.02B | 1.05B | 1.20B | 1.19B | 1.37B | 1.65B | 1.75B | 1.79B | 1.76B | 1.63B | 1.42B | 1.46B | 1.42B | 1.38B | 1.48B | 1.56B | 1.55B | 1.72B |
| Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 303.63M | 326.87M | 313.57M | 311.35M | 345.92M | 387.01M | 404.92M | 503.37M |
| Operating Income | 39.29M | 38.81M | 32.72M | 32.51M | 38.16M | 34.40M | 36.14M | 32.51M | 38.16M | 34.40M | 35.03M | 128.95M | 36.75M | 15.56M | 73.74M | 48.55M | 74.12M | 59.86M | 293.29M | 122.83M | 106.29M | 127.45M | 74.36M | 199.51M | 268.26M | 205.66M | 232.90M | 278.61M | 268.33M | 255.84M | 356.68M | 178.37M | 137.17M | 148.50M | 60.11M | 28.40M | 75.87M | 71.73M | 226.77M | 555.24M |
| Net Income | 3.08M | -9.09M | 84.43M | 5.83M | 9.15M | 7.76M | 105.73M | 5.83M | 9.15M | 7.76M | 105.73M | 97.31M | -30.42M | -6.04M | 40.65M | 18.01M | 26.26M | 25.72M | 242.61M | 85.51M | 65.44M | 101.12M | 44.74M | 151.77M | 196.58M | 146.81M | 188.05M | 202.00M | 191.08M | 185.80M | 252.38M | 125.03M | 81.16M | 78.87M | 16.95M | -26.16M | 12.66M | 19.36M | 134.31M | 387.31M |
| Diluted EPS | 0.02 | -0.06 | 0.51 | 0.04 | 0.05 | 0.05 | 0.63 | 0.04 | 0.05 | 0.05 | 0.63 | 0.58 | -0.18 | -0.04 | 0.24 | 0.11 | 0.16 | 0.15 | 1.44 | 0.51 | 0.39 | 0.61 | 0.27 | 0.90 | 1.17 | 0.88 | 1.14 | 1.23 | 1.17 | 1.14 | 1.55 | 0.77 | 0.50 | 0.49 | 0.11 | -0.16 | 0.08 | 0.12 | 0.83 | 2.41 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Jan 2009 | Jan 2010 | Jan 2011 | Dec 2011 | Dec 2012 | Dec 2013 | Jan 2015 | Jan 2016 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Jan 2021 | Dec 2021 | Jan 2022 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 | Jan 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 807.49M | 597.81M | 724.91M | 1.80B | 1.77B | 1.80B | 3.96B | 3.39B | 3.39B | 3.66B | 3.39B | 3.36B | 3.57B | - | 4.74B | 6.53B | 6.79B | 5.72B | 6.14B | 6.14B |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 5.00B | 5.14B | 4.44B | 4.66B | - |
| Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.53B | 1.65B | 1.28B | 1.47B | 1.47B |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 831.33M | 1.04B | 995.93M | 1.06B | - |
| Operating Income | 92.68M | 70.94M | 82.46M | 313.98M | 231.74M | 169.57M | 164.51M | 142.64M | 154.73M | 169.44M | 255.00M | 475.82M | 430.94M | - | 884.47M | 698.27M | 600.47M | 281.91M | 413.80M | 273.44M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.41B | 1.48B | 1.01B | 791.81M | - |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 125.57M | 259.22M | 253.86M | 222.28M | - |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 893.72M | 719.96M | 247.51M | 61.03M | - |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 146.63M | 59.57M | -38.34M | -9.36M | - |
| Net Income | 54.56M | 41.79M | 44.24M | 169.42M | 130.77M | 108.97M | 64.22M | 78.53M | 102.31M | 128.47M | 101.50M | 312.60M | 296.82M | - | 650.91M | 737.69M | 647.73M | 278.88M | 62.80M | 62.80M |
| Diluted EPS | 0.66 | 0.51 | 0.53 | 1.47 | 1.11 | 0.91 | 0.39 | 0.48 | 0.62 | 0.77 | 0.60 | 1.86 | 1.78 | - | 3.90 | 4.49 | 3.99 | 1.73 | 0.39 | 0.39 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2007 | Jan 2009 | Jan 2010 | Jan 2011 | Dec 2011 | Dec 2012 | Dec 2013 | Jan 2015 | Jan 2016 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Jan 2021 | Jan 2022 | Dec 2022 | Dec 2023 | Dec 2024 | Jan 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | - | 426.17M | 1.38B | 1.42B | 1.55B | 3.24B | 5.13B | 4.76B | 4.70B | 4.96B | 4.89B | 5.35B | 5.61B | 6.13B | 9.20B | 11.06B | 10.07B | 10.30B |
| Total Equity | 200.98M | 236.58M | 284.88M | 464.30M | 920.38M | 1.06B | 2.02B | 1.95B | 1.87B | 1.97B | 2.24B | 2.27B | 2.57B | 2.89B | 3.28B | 3.81B | 4.61B | 4.38B | 4.74B |
| Cash & Equivalents | 16.34M | 50.81M | 68.18M | 38.94M | 38.94M | 103.25M | 870.86M | 108.78M | 156.88M | 114.56M | 106.77M | 107.26M | 72.94M | 81.62M | 68.91M | 127.02M | 126.50M | 75.97M | 88.67M |
| Long Term Debt | - | - | 27.54M | 707.03M | 280.02M | 250.14M | 866.95M | 2.10B | 1.91B | - | - | - | - | - | - | - | - | - | - |
| Total Liabilities | - | - | 141.29M | 917.96M | 496.65M | 489.98M | 1.22B | 3.08B | 2.79B | 2.62B | 2.63B | 2.55B | 2.70B | 2.66B | 2.79B | 5.31B | 6.37B | 5.61B | 5.49B |
| Current Liabilities | - | - | 71.28M | 154.83M | 127.26M | 131.68M | 176.80M | 483.40M | 441.67M | 451.85M | 559.48M | 540.50M | 688.34M | 675.30M | 752.68M | 1.07B | 998.14M | 1.04B | 1.03B |
Cash Flows (Annual)
Figures in USD.
| Metric | Jan 2009 | Jan 2010 | Jan 2011 | Dec 2011 | Dec 2012 | Dec 2013 | Jan 2015 | Jan 2016 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Jan 2021 | Jan 2022 | Dec 2022 | Dec 2023 | Dec 2024 | Jan 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 91.95M | 79.19M | 81.51M | 240.86M | 249.54M | 210.72M | 275.17M | 420.96M | 391.00M | 410.44M | 398.62M | 362.62M | 624.65M | 704.42M | 813.74M | 899.26M | 839.29M | 1.06B |
| Investing Cash Flow | -52.39M | -55.71M | -783.64M | -83.68M | -153.83M | -895.42M | -2.32B | -229.67M | -243.19M | -284.05M | -342.42M | -338.07M | -310.63M | -490.26M | -2.42B | -1.68B | -498.90M | -681.45M |
| Financing Cash Flow | -5.08M | -6.11M | 653.15M | -137.45M | -31.39M | 1.46B | 1.28B | -139.59M | -183.87M | -154.85M | -47.58M | -54.88M | -306.99M | -221.36M | 1.68B | 876.29M | -399.56M | -376.73M |
| Capital Expenditure | - | - | - | - | - | - | - | - | - | - | -321.90M | -359.50M | -280.12M | -274.13M | -391.31M | -555.48M | -332.46M | -380.48M |
| Free Cash Flow | - | - | - | - | - | - | - | - | - | - | 76.72M | 3.12M | 344.54M | 430.29M | 422.43M | 343.78M | 506.82M | 679.24M |
| Share Buybacks | - | - | - | - | - | 0 | 0 | 5.91M | 5.00M | 0 | 0 | 19.26M | 55.04M | 167.71M | 125.53M | 52.94M | 34.27M | 34.67M |
Ratios (Annual)
Figures in %.
| Metric | Jan 2009 | Jan 2010 | Jan 2011 | Dec 2011 | Dec 2012 | Dec 2013 | Jan 2015 | Jan 2016 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Jan 2021 | Dec 2021 | Jan 2022 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 | Jan 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 23.4% | 24.2% | 22.4% | 24.0% | 24.0% |
| Operating Margin % | 11.5% | 11.9% | 11.4% | 17.5% | 13.1% | 9.4% | 4.2% | 4.2% | 4.6% | 4.6% | 7.5% | 14.1% | 12.1% | - | 18.7% | 10.7% | 8.8% | 4.9% | 6.7% | 4.5% |
| Net Margin % | 6.8% | 7.0% | 6.1% | 9.4% | 7.4% | 6.0% | 1.6% | 2.3% | 3.0% | 3.5% | 3.0% | 9.3% | 8.3% | - | 13.7% | 11.3% | 9.5% | 4.9% | 1.0% | 1.0% |
| ROE % | 23.1% | 14.7% | 9.5% | 18.4% | 12.3% | 5.4% | 3.3% | 4.2% | 5.2% | 5.7% | 4.5% | 12.2% | 10.3% | - | 19.8% | 19.4% | 14.1% | 6.4% | - | 1.3% |
| ROCE % | - | 20.0% | 6.7% | 24.3% | 16.3% | 5.5% | 3.5% | 3.3% | 3.6% | 3.9% | 5.9% | 10.2% | 8.7% | - | 16.4% | 8.6% | 6.0% | 3.1% | - | 3.0% |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Blackrock Inc. | 9.88% | 15.59M | $1.02B |
| 2 | Vanguard Portfolio Management LLC | 5.29% | 8.35M | $545.90M |
| 3 | Dimensional Fund Advisors LP | 5.21% | 8.22M | $537.12M |
| 4 | Vanguard Capital Management LLC | 4.56% | 7.19M | $470.01M |
| 5 | State Street Corporation | 3.61% | 5.70M | $372.75M |
| 6 | Earnest Partners LLC | 2.58% | 4.08M | $266.41M |
| 7 | Citadel Advisors Llc | 2.56% | 4.04M | $263.81M |
| 8 | AQR Capital Management, LLC | 2.51% | 3.96M | $258.93M |
| 9 | FMR, LLC | 2.38% | 3.76M | $245.56M |
| 10 | Geode Capital Management, LLC | 2.19% | 3.46M | $226.33M |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for DAR
Darling Ingredients (DAR) Stock Looks Undervalued On Broader Checks Yet Fair On Earnings - finance.yahoo.com
<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxNSUx1T3B5Nk1jeFZpdWZGR0FKTXhzN0s2UmpjT2YyZ1V0R29HSzByMGNTaTBaamxGX3hjTVlxVmZKeDMyR2duZzJ2RDVkcDU2Q0ZtZnNlM0Q3cy0tR1hLYkQtOFpodGZkUlVMTmtOX2lKam5RMmM3ejBNdThTUjk3TEM1WkgzX0hzQzNEZ2…
Darling Ingredients (DAR) Stock Looks About Right With Discounted Broader Checks - simplywall.st
<a href="https://news.google.com/rss/articles/CBMi4gFBVV95cUxNNGg0UkY1REoxSmJ4a3NITmJkV3ZWQUI1T29UeTkyYm51dGZSRjAySlBtbUoweFRwdDlYMUt4d2pyQVhMNVBhU2FKZmxxSVhCV0hhN2lUQk92eGRLakc1LWNzaWhwNVhkR21Jc0dtQ3puVk8wV3Bva052XzZITmJwakNnal9DMjNmZklmd0…
AXQ Capital LP Sells 16,780 Shares of Darling Ingredients Inc. $DAR - marketbeat.com
<a href="https://news.google.com/rss/articles/CBMiwwFBVV95cUxNbnV5M1lkOUkxWWZ2UG5sNDB4MWVRVkVWdlR5R1VocFpXR1Y0czZPeElJQUZHV2IzYVhuTHhDRml2TzdmZFpHeFROVDlVTTRramdpLWl0LWhBZWFLYWxkTlljOW95TG5vOXd2Q21BOXhUbGxZdnBXajMzNEpXOXc2VUIwc0FtdURsLU83NU…
Darling Ingredients (NYSE: DAR) CEO plans new 5,000-share sale after July trades - Stock Titan
<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxOTFJZYkxiNjhnWEo3ZDh6TmpxbkdOZjdlSkdoRVd6V2d2aWExdEZ2Yjd5M0hqRXZCNzlPVWZzZTI0UjN0c0tkS3hMRWs4V21MaXNXa2N0TTl3VXpsM21XOEVrRjFKVTlnNnFvSkFUa05KSm9xYTNBWE9fYThEaFNxT3BjRzZIaUhBQ2ZDem…
Darling Ingredients (DAR) Chairman and CEO Randall Stuewe Sells 5,000 Shares - gurufocus.com
<a href="https://news.google.com/rss/articles/CBMisgFBVV95cUxOVlpmdkIza1JJSy1TcXNlNjlkdThUNGhIX1YzdGd0REgyMGdSTWxKVkxTOHFrN1MyY0Q1NDUzTnJtRWdpOUNjelBSSFJVbGozYWM0T2dIZ2g0RGJ3ek5kcFA1RWM2QUxpMDVWdk9kSU1oUndUbE5vb05mUzZpWHd5aU5sdTd2OHhTUkZyS1…
Should Value Investors Buy Darling Ingredients (DAR) Stock? - finance.yahoo.com
<a href="https://news.google.com/rss/articles/CBMipwFBVV95cUxPbWozTEVQcUptRjJ3aW45QnE4eGNPekVhMnZXUGQ5Q0lmdjBhb2xWV1VKN0NTWnNqclpFU292V19LcS1DNE5wYXR4WHl1WEtHME45OEQyVE1kd21PWUZ6ejgyYmlkLWlERHRUUzVSOGtuU081X0t6SFJhVHR2ejNkb3g0YkFYQlFjeUlLUn…
DAR — Frequently Asked Questions
What is the current share price of Darling Ingredients Inc. (DAR)?
As of 2026-09-19 21:16 PDT, Darling Ingredients Inc. (DAR) trades at $67.11 on NYSE. Its 52-week range is $29.91 to $68.34.
What is the market capitalisation of DAR?
Darling Ingredients Inc. (DAR) has a market capitalisation of $10.59B on NYSE.
What is the P/E ratio of DAR?
DAR trades at a trailing price-to-earnings (P/E) ratio of 18.04. The industry average P/E is 18.56. Its price-to-book (P/B) ratio is 2.03.
What is the return on equity (ROE) of DAR?
DAR has a return on equity (ROE) of 12.13%. Its return on capital employed (ROCE) is 2.95%.
Is DAR a good stock to buy?
This page provides a data-driven analysis of Darling Ingredients Inc. (DAR), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.